Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference34 articles.
1. Grundy SM, Cleeman JI, Merz CN, et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol 2004, 24:e149-e161.
2. Jeu L, Cheng JW: Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor. Clin Ther 2003, 25:2352–2387.
3. Gagne C, Bays HE, Weiss SR, et al.: Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol 2002, 90:1084–1091.
4. Kosoglou T, Statkevich P, Yang B, et al.: Pharmacodynamic interaction between ezetimibe and rosuvastatin. Curr Med Res Opin 2004, 20:1185–1195.
5. Schuster H, Fox JC: Investigating cardiovascular risk reduction the Rosuvastatin GALAXY Programme. Expert Opin Pharmacother 2004, 5:1187–1200.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献